Behanna Heather 4
4 · Entasis Therapeutics Holdings Inc. · Filed Feb 15, 2022
Insider Transaction Report
Form 4
Berger Heather A.
Director
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2021-07-16−7,500→ 0 totalExercise: $6.12Exp: 2029-06-18→ Common Stock (7,500 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2021-07-16−15,000→ 0 totalExercise: $5.66Exp: 2029-01-17→ Common Stock (15,000 underlying) - Award
Stock Option (Right to Buy)
2021-07-16+11,538→ 11,538 totalExercise: $2.44Exp: 2031-07-15→ Common Stock (11,538 underlying) - Award
Stock Option (Right to Buy)
2021-07-16+5,769→ 5,769 totalExercise: $2.44Exp: 2031-07-15→ Common Stock (5,769 underlying)
Footnotes (6)
- [F1]The option provided for vesting as follows: The shares subject to this option will vest in full on January 1, 2020, subject to the Reporting Person's continued service through such vesting date.
- [F2]On July 16, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 15,000 shares of issuer's common stock granted to the Reporting Person on January 18, 2019. In exchange, the Reporting Person received a replacement option for 11,538 shares of issuer's common stock, having an exercise price of $2.44 per share.
- [F3]The shares subject to this option will vest in full on July 16, 2022, subject to the Reporting Person's continuing to provide service through such date.
- [F4]The option provided for vesting as follows: The shares subject to this option will vest in equal monthly installments over the 12 months following the date of grant, provided that the option will in any case be fully vested on the date of the next annual stockholder meeting, subject to the Reporting Person's continued service through each such vesting date.
- [F5]On July 16, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 7,500 shares of issuer's common stock granted to the Reporting Person on June 19, 2019. In exchange, the Reporting Person received a replacement option for 5,769 shares of issuer's common stock, having an exercise price of $2.44 per share.
- [F6]The shares subject to this option will vest in full on July 16, 2022, subject to the Reporting Person's continuing to provide service through such date.